Literature DB >> 106010

Macrophage activation during experimental murine brucellosis: a basis for chronic infection.

C Cheers, F Pagram.   

Abstract

Evidence is presented that the chronicity of infection in CBA mice after injection of Brucella abortus 19 is related to a number of factors: (i) the relative resistance of B. abortus to macrophage killing, which allowed some bacteria to survive the peak of macrophage activity occurring at 14 days; (ii) the decline in macrophage activity thereafter (this decline was related in part to the presence of fewer bacteria to stimulate the bactericidal activity and also to specific, active suppressor mechanisms not identified in this study); and (iii) the insensitivity of the persistent Brucella organisms to activated macrophages. This was not due to a selection of genetically resistant bacteria, but possibly to their inaccessibility, either within "incompetent" macrophages or outside macrophages altogether.

Entities:  

Mesh:

Year:  1979        PMID: 106010      PMCID: PMC414148          DOI: 10.1128/iai.23.2.197-205.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  T-dependent suppression of the primary antibody response to sheep erythrocytes in mice infected with Trichinella spiralis.

Authors:  J F Jones; C A Crandall; R B Crandall
Journal:  Cell Immunol       Date:  1976-11       Impact factor: 4.868

2.  Suppressor cells in experimentally trypanosomiasis.

Authors:  A N Jayawardena; B H Waksman
Journal:  Nature       Date:  1977-02-10       Impact factor: 49.962

3.  Biological effects of the adjuvant Corynebacterium parvum. II. Evidence for macrophage-T-cell interaction.

Authors:  M T Scott
Journal:  Cell Immunol       Date:  1972-11       Impact factor: 4.868

4.  On the mode of action of BCG.

Authors:  M S Mitchell; D Kirkpatrick; M B Mokyr; I Gery
Journal:  Nat New Biol       Date:  1973-06-13

5.  Nature of "memory" in T-cell mediated antibacterial immunity: cellular parameters that distinguish between the active immune response and a state of "memory".

Authors:  R J North; J F Deissler
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

6.  Polyadenylic acid-polyuridylic acid (poly A : U) and experimental murine brucellosis. II. Macrophages as target cells of poly A : U in experimental brucellosis.

Authors:  E D Madraso; C Cheers
Journal:  Immunology       Date:  1978-07       Impact factor: 7.397

7.  The enhancement of macrophage bacteriostasis by products of activated lymphocytes.

Authors:  R E Fowles; I M Fajardo; J L Leibowitch; J R David
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

8.  Resistance of Brucella abortus infected mice to intravenous or intraperitoneal Brucella reinfection.

Authors:  P Pardon; J Marly
Journal:  Ann Immunol (Paris)       Date:  1976 Jan-Feb

9.  Cell-mediated immune response to Salmonella typhimurium infection in mice: development of nonspecific bactericidal activity against Listeria monocytogenes.

Authors:  R M Zinkernagel
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

10.  Endotoxic activity of rough organisms of Brucella species.

Authors:  L M Jones; R Diaz; D T Berman
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

View more
  18 in total

1.  Comparative protection of mice against virulent and attenuated strains of Brucella abortus by passive transfer of immune T cells or serum.

Authors:  L N Araya; A J Winter
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

2.  Collaboration of bovine T lymphocytes and macrophages in T-lymphocyte response to Brucella abortus.

Authors:  G A Splitter; K M Everlith
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

3.  Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice.

Authors:  J A Montaraz; A J Winter
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

4.  Differential regulation of effector responses of cell mediated immunity in experimental salmonellosis.

Authors:  A George; S Rath; R S Kamat
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

5.  Ia antigens in serum during different murine infections.

Authors:  C R Parish; R R Freeman; I F McKenzie; C Cheers; G A Cole
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

6.  Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice.

Authors:  E A Murphy; J Sathiyaseelan; M A Parent; B Zou; C L Baldwin
Journal:  Immunology       Date:  2001-08       Impact factor: 7.397

7.  Prophylaxis or treatment of experimental brucellosis with interleukin-1.

Authors:  Y F Zhan; E R Stanley; C Cheers
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

8.  Construction of Cu-Zn superoxide dismutase deletion mutants of Brucella abortus: analysis of survival in vitro in epithelial and phagocytic cells and in vivo in mice.

Authors:  F M Tatum; P G Detilleux; J M Sacks; S M Halling
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

9.  Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis.

Authors:  M P Jiménez de Bagüés; P H Elzer; S M Jones; J M Blasco; F M Enright; G G Schurig; A J Winter
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

10.  Immunomodulation by Blastomyces dermatitidis: functional activity of murine peritoneal macrophages.

Authors:  L S McDaniel; G C Cozad
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.